CCL Healthcare

CCL Healthcare offers an extensive range of top-quality secondary packaging and labeling solutions. Developed by leading designers and engineers, our products lead the industry in quality and innovation. Tested thoroughly, available in various configurations, and customizable, we incorporate innovative fea...

CCL Healthcare’s printed literature options are designed to meet the regulatory, multilingual, and instructional demands of the healthcare packaging industry. Our wide range of high-capacity folded package inserts, outserts, padded inserts, booklets, glued pads, and more provide ample space for detailed le...

CCL Healthcare specializes in pharmaceutical folding cartons are manufactured in cGMP facilities to ISO standards. Our specialization in the pharmaceutical folding cartons offers our customers a large range of custom designs, construction, closures, and specialty features to enhance the functiona...

CCL Healthcare, a division of CCL Label, is focused on producing secondary packaging within cGMP facilities. We pride ourselves in partnering globally with companies of all sizes and manufacturing our products locally to our partners. That is why we have 38+ cGMP facilities worldwide and are growing. With over 70 years of printing experience, CCL Healthcare knows quality matters. That is why we have invested heavily into 100% Vision Inspection Systems and deployed the most rigorous Quality Assurance process in the industry. What does this mean for our partners? CCL Healthcare is dedicated to providing our partners with the lowest cost of ownership in the industry. Our products are designed to increase packaging line throughput, minimize the investment in equipment, and deliver the highest quality products on the market.

Counterfeit medication is a growing global threat, particularly with the rise of blockbuster self-administered treatments. The consequences are dire—patients risk severe medical complications, in the worst cases, fatal outcomes from unknowingly injecting counterfeit drugs. For pharmaceutical manufacturers, the stakes are equally high, with counterfeit drugs costing the industry an estimated $200 billion annually—excluding potential legal liabilities and costly recalls. The need for robust solutions to safeguard patients and protect brand integrity has never been more critical. Learn How RFID Enabled Medication Can: Enhance Patient Safety Improve Trust and Brand Integrity Provide Item-Level Digital Identity Streamline Recalls Reduce Financial Losses Improved Supply Chain Transparency Create a Competitive Advantage